Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,932.84 +141.98 (+0.20%) CMC Crypto 200
1,516.39 +27.85 (+1.87%)
BCRX Jun 2024 6.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
| Previous close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.6500 |
| Ask | 0.7000 |
| Strike | 6.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.4000 - 0.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.15k |
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.comInsider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.